365bet娱乐

Summary of article contents:

Overweight and obesity are the fifth leading risk for global death. It is a major risk factor for serious non-communicable diseases, such as CVD, hypertension, stroke, DM etc. Various medicines are available for the management but results are unsatisfactory and prevention is the only alternative. It is told that there is no other medicine as diet. So there is a need to find a suitable measure for this purpose. To assess the efficacy of Madhoodak & Gomutra Arka in the management of Sthaulya & compare their effect. In present clinical trial 40 patient aged between 20 to 45 years, reporting BMI in between 25 to 40 kg/m², having clinical signs and symptoms of Sthaulya were selected from O.P.D. & I.P.D. & Yoga Unit of NIA Hospital, Jaipur, Rajasthan, and registered following written consent. Registered patients were randomly divided into two groups. Group A has been administered with Gomutra Arka聽& Group M has been administered with Madhoodak , once in a day.聽 Follow up has been recorded after every fortnight for the duration of 3 month. The efficacy of therapy was assessed on the basis of various subjective & objective criterion such as Chala Sphika-Udara-Stana, Alasya, Kshudrashwasa, Daurbalya,Weight, BMI & circumference measurements,S. Cholesterol, S. Triglyceride, HDL, LDL and VLDL etc. Both the groups showed statistically highly significant (p<0.001) results in all the Subjective, Objective, Anthropometric & Laboratorial parameters except in Alpa vyavaya & Gatra sada. Group A showed better percentage of relief in maximum parameters except in Daurbalya, Atipipasa, Atikshudha, & Alpavyavaya. These are the only symptoms in which Madhoodak Group showed maximum percentage relief.The Gomutra Arka & Madhoodak both are safe, cost effective and free from side effects & can be used for effective management of Sthaulya and in comparison Gomutra Arka is better.